YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
This article first appeared on GuruFocus. Net Sales (Q2 2026): SEK272 million, a decrease of 11% year-over-year, with organic growth of negative 8%. Net Sales (Last 12 Months): SEK1.27 billion, with organic growth of 9%. Operating Profit (…
* RaySearch Laboratories press release [https://storage.mfn.se/98a556d0-12e7-4a1d-95e6-c312f522e8e2/raysearch-interim-report-q2-2026.pdf] (RSLBF [https://seekingalpha.com/symbol/RSLBF]): Q2 GAAP EPS of SEK 0.57. * Revenue of SEK 272.3M (-1…
As European markets navigate through volatility, with the pan-European STOXX Europe 600 Index recently hitting a new high but ending broadly unchanged, investors are keenly observing how AI disruption concerns and better-than-expected U.S.…
The European market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index declining by 0.98% amid ongoing trade and geopolitical uncertainties, reflecting broader challenges in major indices such as France's CAC…
As the pan-European STOXX Europe 600 Index shows resilience with a 0.77% rise, supported by robust economic data and earnings results, small-cap stocks in Europe are gaining attention amid mixed performances across major indexes. With Germ…
As European markets show optimism with the STOXX Europe 600 Index rising 2.27% amid a strengthening eurozone economy, investors are increasingly focused on growth companies that insiders are eager to own. In this environment, stocks with h…
As European markets close out a holiday-shortened week, the pan-European STOXX Europe 600 Index edged slightly higher, buoyed by positive sentiment around future earnings and economic prospects. In this environment, identifying promising t…
As the European market navigates a landscape marked by mixed stock index performances and economic indicators, investor attention is drawn to growth companies with strong insider ownership, particularly those anticipating revenue growth. I…
As European markets grapple with concerns over inflated AI stock valuations and shifting interest rate expectations, the pan-European STOXX Europe 600 Index recently declined by 2.21%, reflecting broader sentiment challenges. In this clima…
Amid recent fluctuations in global markets, European stocks have faced pressure from concerns over AI valuations and shifting interest rate expectations. Despite these challenges, the expansion of business activity in the eurozone suggests…
As European markets experience a pullback, with the pan-European STOXX Europe 600 Index ending 1.24% lower amid concerns about overvaluation in AI-related stocks, investors are increasingly focused on identifying robust growth opportunitie…
As European markets experience a notable upswing, with the STOXX Europe 600 Index climbing 1.68% and key indices in Germany, Italy, France, and the UK showing positive momentum, investors are increasingly focused on high-growth sectors suc…
As European markets face a downturn with the STOXX Europe 600 Index ending 1.10% lower amid political turmoil and trade tensions, investors are increasingly drawn to companies where insiders hold significant stakes, signaling confidence in…
As the European market navigates through a landscape of cautious optimism, with the pan-European STOXX Europe 600 Index ending mostly unchanged amid interest rate assessments and trade concerns, investors are keenly observing sectors showi…
Amidst a backdrop of political instability and economic uncertainty, the European market has seen its indices, such as the STOXX Europe 600, decline due to concerns over U.S. Federal Reserve independence and geopolitical tensions. In this…
As European markets experience a positive upswing, with the STOXX Europe 600 Index climbing on strong corporate earnings and optimism surrounding geopolitical tensions, investors are increasingly looking towards growth companies with high…
Amidst a backdrop of global trade tensions and economic uncertainty, the European stock market has seen notable fluctuations, with the pan-European STOXX Europe 600 Index recently declining by 2.57% due to dissatisfaction with a new trade…
As the pan-European STOXX Europe 600 Index remains steady amid ongoing U.S. and European trade discussions, investors are keenly observing economic indicators like industrial production growth and widening trade surpluses in the eurozone.…
As the pan-European STOXX Europe 600 Index continues its upward trajectory, marking a fourth consecutive week of gains amid easing trade tensions between China and the U.S., investors are closely watching how these developments influence h…
In the midst of escalating trade tensions and fluctuating consumer sentiment, European markets have experienced a turbulent period, with the pan-European STOXX Europe 600 Index ending 1.92% lower amid heightened vigilance from central bank…
Amid heightened trade tensions and economic uncertainties, the European market has experienced fluctuations, with the STOXX Europe 600 Index recently closing 1.92% lower. As central banks in the eurozone and UK increase their vigilance, in…
RaySearch Laboratories AB (publ) announces that Southwest Florida Proton, USA, has placed an order for the treatment planning system RayStation®* to be installed at its new proton center in Estero, Florida. STOCKHOLM, July 12, 2023 /PRNews…
STOCKHOLM, June 16, 2023 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) in Adelaide, Australia has placed an order for the oncology information system Ra…
STOCKHOLM, April 28, 2023 /PRNewswire/ -- Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2022. The report is held available on RaySearch's website, under the section Investors. This information i…
A new consortium for the advancement of Proton Online Adaptive Radiation Therapy, ProtOnART, uniquely brings together researchers, clinicians, and industry. The members of the ProtOnART consortium are OncoRay in Dresden, Germany, and PARTI…
STOCKHOLM, June 3, 2022 /PRNewswire/ -- RaySearch issues a correction of the press release that was sent out at 4 pm CEST on June 3, 2022. The correction refers to the fact that the date of sale of shares should have been May 31, 2022. The…
STOCKHOLM, May 26, 2021 /PRNewswire/ -- In light of the corona pandemic, the Annual General Meeting 2021 of RaySearch Laboratories AB (publ) was held only through postal voting in accordance with temporary legislation. The following resolu…
STOCKHOLM, May 26, 2021 /PRNewswire/ -- In light of the corona pandemic, the Annual General Meeting 2021 of RaySearch Laboratories AB (publ) was held only through postal voting in accordance with temporary legislation. The following resolu…
STOCKHOLM, July 15, 2020 /PRNewswire/ -- RaySearch Laboratories AB (publ) has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeam™ System for boron neutron capture therapy (BNCT). BNCT…
STOCKHOLM, July 15, 2020 /PRNewswire/ -- RaySearch Laboratories AB (publ) has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeam™ System for boron neutron capture therapy (BNCT). BNCT…
STOCKHOLM, May 28, 2020 /PRNewswire/ -- RaySearch Laboratories AB (publ) and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare®* oncology information system to connect to Varian TrueBeam lin…
STOCKHOLM, May 26, 2020 /PRNewswire/ -- The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Tuesday, June 30, 2020, at 4:00 p.m., at the…
RaySearch Laboratories (STO:RAY B) shareholders are no doubt pleased to see that the share price has bounced 45% in the last month alone, although it is still down 10% over the last quarter. But shareholders may not all be feeling jubilant…
A week ago, RaySearch Laboratories AB (publ) (STO:RAY B) came out with a strong set of first-quarter numbers that could potentially lead to a re-rate of the stock. RaySearch Laboratories delivered a significant beat to revenue and earnings…
RaySearch Laboratories (STO:RAY B) shareholders are no doubt pleased to see that the share price has bounced 33% in the last month alone, although it is still down 26% over the last quarter. But shareholders may not all be feeling jubilant…
Most readers would already be aware that RaySearch Laboratories' (STO:RAY B) stock increased significantly by 36% over the past month. However, we wonder if the company's inconsistent financials would have any adverse impact on the current…